市场调查报告书
商品编码
1535147
PTA 球囊导管市场:依细分市场划分的规模、占有率、法规、偿付、程序、到2033年的预测PTA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
PTA 球囊导管是一种球囊,插入受影响的动脉并充气,将斑块推向动脉壁,扩宽动脉并改善血流。导管透过皮肤上的小切口插入动脉,并使用 X 光和超音波等影像技术引导至阻塞处。
使用标准 PTA 球囊导管的微创技术治疗週边动脉疾病(PAD),该技术用于打开因斑块堆积(动脉粥状硬化)而阻塞的动脉。 PTA 週边 DEB 导管是一种药物涂层经皮腔内血管成形术(PTA)球囊,目的是预防週边动脉再狭窄。
本报告深入探讨了全球 PTA 球囊导管市场,包括竞争格局、SWOT 分析、到2033年的市场预测以及区域和国家趋势。
PTA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.
A PTA balloon catheter is a type of balloon that is inserted into the affected artery and inflated to push the plaque against the walls of the artery, thus widening the artery and improving blood flow. The catheter is inserted into the artery through a small incision in the skin and guided to the site of the blockage using imaging techniques such as X-ray or ultrasound.
Minimally Invasive technique is used to treat Peripheral artery disease (PAD) with the help of Standard PTA Balloon Catheters that are used to open up the arteries that are blocked by plaque build-up (atherosclerosis). PTA Peripheral DEB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed PTA Balloon Catheters and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Becton Dickinson and Co, Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Koninklijke Philips NV, Shockwave Medical Inc, Cardinal Health Inc, Cook Group Inc, B. Braun Melsungen AG, Terumo Corp, Acotec Scientific Holdings Ltd, Kaneka Corp, Lepu Medical Technology (Beijing) Co Ltd, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -